News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: ChemPartner's Scientific Expertise



12/30/2013 9:44:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

December 28, 2013 --Dr. Arthur Taveras, President and CSO of ChemPartner, told ChinaBio® Today in an exclusive interview that the depth of ChemPartner’s scientific knowledge sets the CRO apart from its competition; Shenzhen Hepalink Pharma purchased Scientific Protein Laboratories, a US maker of heparin API, for $337.5 million; Walvax Biotech will acquire 64% of Shanghai’s Genor BioPharma, paying $49 million; Neurotron Biotechnology, a Hangzhou medical device company developing a cochlear implant, raised “as much as” $16.5 million in a C round; eight young children died in China after developing adverse reactions to a hepatitis B vaccine; TaiGen Biotech, a Taiwan-Beijing company, said the US FDA granted its lead antibiotic drug a five-year extension to the antibiotic’s exclusivity, priority review and fast track status. More details….

Stock Symbols: (SHE: 002399) (SHE: 300142)

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES